UK markets closed

STAAR Surgical Company (STAA)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
45.51-0.03 (-0.07%)
At close: 04:00PM EDT
45.51 0.00 (0.00%)
After hours: 04:01PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 2.24B
Enterprise value 2.05B
Trailing P/E 105.84
Forward P/E 158.73
PEG ratio (5-yr expected) N/A
Price/sales (ttm)6.98
Price/book (mrq)5.79
Enterprise value/revenue 6.36
Enterprise value/EBITDA 61.74

Trading information

Stock price history

Beta (5Y monthly) 0.88
52-week change 3-32.66%
S&P500 52-week change 322.38%
52-week high 368.27
52-week low 326.66
50-day moving average 340.93
200-day moving average 338.63

Share statistics

Avg vol (3-month) 3715.38k
Avg vol (10-day) 3466.27k
Shares outstanding 549.13M
Implied shares outstanding 648.87M
Float 837.5M
% held by insiders 10.51%
% held by institutions 1106.37%
Shares short (15 Apr 2024) 44.87M
Short ratio (15 Apr 2024) 45.66
Short % of float (15 Apr 2024) 420.63%
Short % of shares outstanding (15 Apr 2024) 49.98%
Shares short (prior month 15 Mar 2024) 45.43M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 21:2
Last split date 318 May 1992

Financial highlights

Fiscal year

Fiscal year ends 29 Dec 2023
Most-recent quarter (mrq)29 Dec 2023

Profitability

Profit margin 6.62%
Operating margin (ttm)15.55%

Management effectiveness

Return on assets (ttm)4.09%
Return on equity (ttm)5.91%

Income statement

Revenue (ttm)322.42M
Revenue per share (ttm)6.64
Quarterly revenue growth (yoy)19.10%
Gross profit (ttm)N/A
EBITDA 34.83M
Net income avi to common (ttm)21.35M
Diluted EPS (ttm)0.43
Quarterly earnings growth (yoy)14.70%

Balance sheet

Total cash (mrq)220.73M
Total cash per share (mrq)4.52
Total debt (mrq)35.83M
Total debt/equity (mrq)9.28%
Current ratio (mrq)5.62
Book value per share (mrq)7.91

Cash flow statement

Operating cash flow (ttm)14.59M
Levered free cash flow (ttm)-2.79M